中文

Hong Kong Stocks · Free Data Page

GENSCRIPT BIO 01548

GENSCRIPT BIO: FY2025 revenue $959.5M (+61.40% YoY); net income -$532.8M; 1 alert, 2 watch items out of 17 risk checks; no TTM dividend.
Close PriceHK$34.00Day +12.51%Market CapHK$77.66BP/E—Negative earningsP/B2.55xROE (FY2025)-12.9%Avg. equity

Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for GENSCRIPT BIO?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2016–2025

Financial statements are reported in USD, while share price and market cap are quoted in HKD.

Key Multi-Year Facts

  • Revenue moved from $114.7M in FY2016 to $959.5M in FY2025 (9-year CAGR +26.6%).
  • Net income was negative in FY2019, FY2020, FY2021, FY2022, FY2023, FY2025.
  • Operating cash flow was below half of net income in FY2024.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (USD B)0.490.630.560.590.96
YoY25.4%27.7%-10.4%6.1%61.4%
Net Income (USD B)-0.36-0.23-0.102.96-0.53
YoY————-118.0%
Operating Cash Flow (USD B)-0.87-0.84-2.030.542.29
ROE-36.8%-22.1%-8.0%103.7%-12.9%
Gross Margin57.6%48.6%48.3%45.8%57.7%
Net Margin-73.2%-36.3%-17.0%498.2%-55.5%
Debt-to-Assets37.9%46.5%39.6%18.1%18.3%
Show all 10 fiscal years
Fiscal Year2016201720182019202020212022202320242025
Revenue (USD B)0.110.150.230.270.390.490.630.560.590.96
YoY—33.0%51.3%18.3%43.0%25.4%27.7%-10.4%6.1%61.4%
Net Income (USD B)0.030.030.02-0.10-0.20-0.36-0.23-0.102.96-0.53
YoY—-0.2%-18.8%-556.8%—————-118.0%
Operating Cash Flow (USD B)0.230.142.11-0.21-0.99-0.87-0.84-2.030.542.29
ROE14.7%13.2%6.1%-22.5%-31.9%-36.8%-22.1%-8.0%103.7%-12.9%
Gross Margin66.4%68.5%68.6%66.0%65.5%57.6%48.6%48.3%45.8%57.7%
Net Margin22.8%17.1%9.2%-35.5%-52.4%-73.2%-36.3%-17.0%498.2%-55.5%
Debt-to-Assets18.6%54.7%46.2%58.1%43.7%37.9%46.5%39.6%18.1%18.3%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-05

Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).

1Alert 2Watch 13Pass 1N/A

Items Flagged for Review

  • Alert

    Interest CoverageSolvency

    Negative (negative EBIT)

    FY2025 (ended 2025-12-31) · What is this?

  • Watch

    Net LossesGoing Concern

    FY2025 (2025-12-31) $-0.53B, FY2024 (2024-12-31) $2.96B

    FY2025 (ended 2025-12-31)

  • Watch

    Profit WarningMaterial Events

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

Dividends

No dividends paid over the trailing 12 months.

Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.

More data: All research reports · Sector leaders · Market hours & holidays.

Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.